Skip to Content
Find More Like This
Return to Search

Recombinant herpes simplex virus useful for treating neoplastic disease

United States Patent

June 29, 2010
View the Complete Patent at the US Patent & Trademark Office
Recombinant herpes simplex viruses comprising DNA encoding cytokines and methods for treating neoplastic diseases using the inventive recombinant viruses are disclosed.
Whitley; Richard J. (Birmingham, AL), Roizman; Bernard (Chicago, IL)
The University of Chicago (Chicago, IL), UAB Research Foundation (Birmingham, AL)
11/ 546,233
October 11, 2006
U.S. GOVERNMENT RIGHTS The U.S. government may own certain rights in the invention pursuant to grants from the National Institutes of Health (NC1-CA47451, NIAID-AI124009, NC1-K12-CA01719, and NINDS-NS31096) and a research grant from the U.S. Department of Energy (DEFG05-93ER61654).